Craig A Sather

Title: Craig A. Sather: Innovator in Pharmaceutical Compositions

Introduction

Craig A. Sather is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize medium chain triglycerides. His work aims to address critical health conditions, including Alzheimer's disease.

Latest Patents

Craig A. Sather holds 1 patent for his invention titled "Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto." This invention focuses on creating high drug load compositions of medium chain triglycerides (MCT) and outlines methods for treatment that effectively elevate ketone body concentrations. Such advancements are crucial for treating conditions associated with reduced neuronal metabolism.

Career Highlights

Sather is currently associated with Cerecin Inc., a company dedicated to developing innovative treatments for neurological conditions. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Craig has collaborated with talented individuals such as Aaron Badenoch and Taryn Boivin. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Craig A. Sather's work in pharmaceutical compositions showcases his commitment to improving health outcomes for individuals with neurological conditions. His innovative approach and collaboration with others in the field continue to drive advancements in medical science.